Pharma Updates
*Update on the European Pharmacopoeia policy on elemental impurities
*Gujarat government announces Biotechnology Policy
*Drug patents expiring in 2017? It's all smoke and mirrors - MedCity News
*Sun Pharma announces positive results in phase 3 study of eye care drug
*2017 RAPS' Regulatory Convergence
*Revision of PIC/S GMP Guide PE 009-13 GUIDE TO GOOD MANUFACTURING PRACTICE
*Cholesterol is finally officially removed from Naughty List
*IPC adds 19 New Impurities Standards for related substance analysis
*FDA Issues List Of Priority Device Guidance For 2017
*ICH Q7 Guideline: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients Q&A
*When Does the Expiration of Pediatric Exclusivity Allow ANDA (or 505(b)(2) NDA) Approval?
*Cabinet okays sale of India's first pharma firm" >
*4 Common Record keeping Mistakes to Look Out For
*PCI instructs colleges to implement new rules & syllabus for B. Pharm & M. Pharm
*Govt invites domestic pharma firms to set up bulk drug clusters
*Watch Out for These 5 Hidden CAPA Pitfalls
*Are vaccine makers influencing India’s immunisation plan?
*Codeine to require a script from 2018
*Prices of 50 essential drugs slashed by up to 44%
*FDA Stresses Scientific Alignment, Not Harmonization For Global Biosimilars
*The Future of BioManufacturing
*FDA Warns Chinese Drugmaker for Refusing Inspection, Unsanitary Conditions
*No fresh approval for cocktail drugs
* Basics and Regulatory aspects Pharmacovigilance by PvPI IPC
*Current Good Manufacturing Practice Requirements for Combination Products
*GMP News: Revised USP Chapter on Analytical Instrument Qualification
*Japanese companies make cautious return to Indian pharma market